Foghorn Therapeutics Therapeutic Compounds Patent Publication
Summary
The European Patent Office has published patent application EP4709726A1 by Foghorn Therapeutics Inc. for therapeutic compounds. The publication includes details on the applicants, inventors, and International Patent Classification codes related to the compounds and their uses.
What changed
The European Patent Office (EPO) has published patent application EP4709726A1, filed by Foghorn Therapeutics Inc., concerning therapeutic compounds and their uses. The publication details the inventors, International Patent Classification (IPC) codes including C07D 471/04, C07D 519/00, A61K 31/5025, and A61P 35/00, and lists designated states across Europe where the patent is applicable.
This publication represents a new patent filing for Foghorn Therapeutics and does not impose immediate compliance obligations on regulated entities. However, it is relevant for entities operating in the pharmaceutical and biotechnology sectors, particularly those involved in drug development and intellectual property management, as it pertains to novel therapeutic compounds. Compliance officers in these sectors should note this publication as part of ongoing landscape monitoring for competitive and technological developments.
Archived snapshot
Mar 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOUNDS AND USES THEREOF
Publication EP4709726A1 Kind: A1 Mar 18, 2026
Applicants
Foghorn Therapeutics Inc.
Inventors
NETHERTON, Matthew, BRUCELLE, Francois, DENG, Jing
IPC Classifications
C07D 471/04 20060101AFI20241115BHEP C07D 519/00 20060101ALI20241115BHEP A61K 31/5025 20060101ALI20241115BHEP A61P 35/00 20060101ALI20241115BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.